Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Thoracic 1Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Sarcoma 4Wilms Tumor 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroblastoma 2Liver Neoplasms 2Kidney Neoplasms 2Astrocytoma 2Testicular Neoplasms 1Teratoma 1Sarcoma, Synovial 1Rhabdomyosarcoma 1Recurrent Uterine Corpus Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Germ Cell Cancer 1Optic Nerve Glioma 1Oligodendroglioma 1Medulloblastoma 1Lung Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Eosinophilic, Acute 1Leukemia 1Head and Neck Neoplasms 1Gliosarcoma 1Glioblastoma 1Familial ependymoma 1Endometrial Adenocarcinoma 1Colonic Neoplasms 1

Interventions

pembrolizumab 5Gemcitabine 5Cisplatin 5Carboplatin 5Fluorouracil 4Filgrastim 4Cetuximab 3fludarabine 2cemiplimab 2belinostat 2atezolizumab 2Temozolomide 2Riluzole 2Peripheral Blood Stem Cell Transplantation 2Oncolytic Virotherapy 2Nivolumab 2Ipilimumab 2Cyclophosphamide 2Bortezomib 2AH 111585 2zanidatamab 1vocimagene amiretrorepvec 1trifluridine tipiracil drug combination 1trastuzumab deruxtecan 1toripalimab 1spartalizumab 1seribantumab 1selpercatinib 1repotrectinib 1poly ICLC 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × ixabepilone × Sarcoma × Clear all
NCT01012362 2017-12-28

Study of Pazopanib and Ixabepilone in Patients With Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
31 enrolled 12 charts
BreastGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Head and Neck Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡